Is Johnson & Johnson overvalued?

Johnson & Johnson (JNJ) looks overvalued — trading about 19% above its fair value.

Overvalued

Price

$271.22

Fair value

$219.55

Current P/E

24.6

Normal P/E

19.9

Market cap

$653.61B

Dividend yield

2.0%

Return on equity

25.7%

Sector

Healthcare

Fair value compares JNJ's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks